John Klier

Leverett, MA, United States of America

John Klier

This inventor holds 7 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: University of Massachusetts, Sirrus, Inc., U.S. Army Research Laboratory. Active years: 2017-2025.

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of John Klier

Introduction

John Klier is a notable inventor based in Leverett, MA (US). He has made significant contributions to the field of biodegradable materials and targeted drug delivery systems. With a total of 7 patents, Klier's work reflects a commitment to advancing sustainable technologies.

Latest Patents

One of Klier's latest patents is titled "Compositions and methods for biodegradable, biomass-based polyesters." This patent focuses on biomass-based polyester materials and outlines methods for their production. It also includes polyester compositions that incorporate these materials along with additional polymers. Another significant patent is "Localization of payload delivery systems to tumor sites via beacon cell targeting." This invention involves nanoparticles designed to deliver payloads specifically to tumor sites, enhancing the effectiveness of treatments.

Career Highlights

Throughout his career, John Klier has worked with esteemed organizations such as the University of Massachusetts and Sirrus, Inc. His experience in these institutions has allowed him to collaborate on innovative projects that push the boundaries of current technology.

Collaborations

Some of Klier's notable coworkers include Aniruddha Palsule and Jeffrey M Sullivan. Their collaborative efforts have contributed to the success of various projects and patents.

Conclusion

John Klier's work exemplifies the intersection of innovation and sustainability. His contributions to biodegradable materials and targeted drug delivery systems are paving the way for future advancements in these critical areas.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…